Search
Menu
Zurich Instruments AG - Boost Your Optics 1-24 LB

Nanoparticle Drug Delivery System Developed at UB

Facebook X LinkedIn Email
BUFFALO, N.Y., August 4 -- Scientists at the University at Buffalo's (UB) Institute for Lasers, Photonics and Biophotonics, working with colleagues at the Roswell Park Cancer Institute, have developed a nonrelease nanoparticle drug delivery system for photodynamic cancer therapy. Because the ceramic-based nanoparticle developed at the university never releases photosensitizing drugs into the bloodstream, it could overcome the main side effect associated with photodynamic cancer therapy (PDT): patients' strong sensitivity to light for four to six weeks after treatment, according to the UB...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: August 2003
    BiophotonicsInstitute for LasersNews & Featuresphotodynamic cancer therapyPhotonics and BiophotonicsRoswell Park Cancer InstituteUniversity at BuffaloLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.